IDENTIFICATION OF SPECIALTY DRUGS
First Claim
Patent Images
1. A method comprising:
- recording, on a computer processor, a drug attribute A score to a drug based on a characteristic level of specialized clinical services associated with patient understanding of a condition that the drug is used to treat, self management of the condition that the drug is used to treat, or both the patient understanding and the self management of the condition that the drug is used to treat;
recording, on the computer processor, a drug attribute B score to the drug based on a characteristic level of specialized requirements for intensive patient training specific to the administration of the drug or specialized requirements for administration of the drug;
recording, on the computer processor, a drug attribute C score to the drug based on a characteristic level of specialized requirements for clinical monitoring required because of toxicity of the drug and to monitor for therapeutic effect;
recording, on the computer processor, a drug attribute D score to the drug based on a characteristic level of an extent of specialized requirements for compliance assistance by a patient associated with the drug to facilitate therapeutic goals;
recording, on the computer processor, a drug attribute E score to the drug based on a characteristic level of an extent of specialized requirements for handling, preparation, and storage of the drug;
recording, on the computer processor, a drug attribute F score to the drug based on a characteristic level of a distribution channel of the drug;
determining, on the computer processor, total value score for the drug based on the drug attribute A score, drug attribute B score, drug attribute C score, drug attribute D score, drug attribute E score, and drug attribute F score;
determining, on the computer processor, a cost attribute for the drug based on location of a cost of the drug within a cost range of a plurality of cost ranges;
identifying, on the computer processor, a numerical threshold value score based on the cost attribute of the drug; and
comparing, on the computer processor, the total value score of the drug against the numerical threshold value score to identify the drug as a specialty drug.
3 Assignments
0 Petitions
Accused Products
Abstract
Methods for determining whether a drug is a specialty drug, methods for creating tools to be used in making the determination, and the tools themselves are disclosed. The overall value of a drug depends on the drug'"'"'s attribute values with respect to each of a set of drug attributes (concerning, e.g., the drug'"'"'s route of administration, targeted disease, possible adverse reactions, risk of toxicity, cost, need for patient compliance with the treatment regime, and handling, preparation, and/or storage requirements. If the overall value or its partial overall values meet certain criteria, the drug is deemed to be a specialty drug.
-
Citations
17 Claims
-
1. A method comprising:
-
recording, on a computer processor, a drug attribute A score to a drug based on a characteristic level of specialized clinical services associated with patient understanding of a condition that the drug is used to treat, self management of the condition that the drug is used to treat, or both the patient understanding and the self management of the condition that the drug is used to treat; recording, on the computer processor, a drug attribute B score to the drug based on a characteristic level of specialized requirements for intensive patient training specific to the administration of the drug or specialized requirements for administration of the drug; recording, on the computer processor, a drug attribute C score to the drug based on a characteristic level of specialized requirements for clinical monitoring required because of toxicity of the drug and to monitor for therapeutic effect; recording, on the computer processor, a drug attribute D score to the drug based on a characteristic level of an extent of specialized requirements for compliance assistance by a patient associated with the drug to facilitate therapeutic goals; recording, on the computer processor, a drug attribute E score to the drug based on a characteristic level of an extent of specialized requirements for handling, preparation, and storage of the drug; recording, on the computer processor, a drug attribute F score to the drug based on a characteristic level of a distribution channel of the drug; determining, on the computer processor, total value score for the drug based on the drug attribute A score, drug attribute B score, drug attribute C score, drug attribute D score, drug attribute E score, and drug attribute F score; determining, on the computer processor, a cost attribute for the drug based on location of a cost of the drug within a cost range of a plurality of cost ranges; identifying, on the computer processor, a numerical threshold value score based on the cost attribute of the drug; and comparing, on the computer processor, the total value score of the drug against the numerical threshold value score to identify the drug as a specialty drug. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)
-
-
17. A non-transitory machine-readable medium comprising instructions, which when executed by one or more processors, cause the one or more processors to perform the following operations:
-
record a drug attribute A score to a drug based on a characteristic level of specialized clinical services associated with patient understanding of a condition that the drug is used to treat, self management of the condition that the drug is used to treat, or both the patient understanding and the self management of the condition that the drug is used to treat; record a drug attribute B score to the drug based on a characteristic level of specialized requirements for intensive patient training specific to the administration of the drug or specialized requirements for administration of the drug; record a drug attribute C score to the drug based on a characteristic level of specialized requirements for clinical monitoring required because of toxicity of the drug and to monitor for therapeutic effect; record a drug attribute D score to the drug based on a characteristic level of an extent of specialized requirements for compliance assistance by a patient associated with the drug to facilitate therapeutic goals; record a drug attribute E score to the drug based on a characteristic level of an extent of specialized requirements for handling, preparation, and storage of the drug; record a drug attribute F score to the drug based on a characteristic level of a distribution channel of the drug; determine total value for the drug based on the drug attribute A score, drug attribute B score, drug attribute C score, drug attribute D score, drug attribute E score, and drug attribute F score; determine a cost attribute for the drug based on location of a cost of the drug within a cost range of a plurality of cost ranges; identify a numerical threshold value based on the cost attribute of the drug; and compare the total value of the drug against the numerical threshold to identify the drug as a specialty drug.
-
Specification